• 3,000 firms
  • Independent
  • Trusted
Save up to 70% on staff

News » Emerging technologies reshape pharma outsourcing, experts say

Emerging technologies reshape pharma outsourcing, experts say

emerging-technologies-reshape-pharma-outsourcing

WEST SUSSEX, UNITED KINGDOM —  In the rapidly evolving pharmaceutical industry, emerging technologies are reshaping the landscape of outsourcing partner evaluations

In an exclusive interview with Outsourcing Pharma, industry experts from software solutions provider CluePoints, including Francois Torche, Steve Young, and Patrick Hughes, shared their insights on how artificial intelligence (AI) and machine learning are revolutionizing drug development and clinical trials.

AI-driven innovation in drug development

Focusing on product development, CluePoints Chief Product & Technology Officer Francois Torche emphasized the transformative power of AI and machine learning in drug development. These technologies enable more efficient data analysis and predictive modeling, significantly reducing the time and cost associated with identifying potential drug candidates. 

CluePoints is at the forefront of this innovation, particularly in Risk-Based Quality Management (RBQM) and centralized monitoring. Their advanced data analytics platform leverages AI to identify and mitigate risks in clinical trials, ensuring prompt issue resolution and improved trial efficiency.

The future of personalized medicine

Torche predicts that the next notable advancements will come from the integration of multi-omics data and the application of AI in personalized medicine. 

This approach promises to improve treatment efficacy and minimize adverse effects, ultimately leading to better patient outcomes.

Enhancing clinical trial quality through RBQM

Focusing on regulations and the TUFTS activity, CluePoints Chief Scientific Officer Steve Young highlighted the latest evidence demonstrating the effectiveness of RBQM in improving clinical trial quality. 

Recent studies have shown significant reductions in protocol deviations and data inconsistencies in trials implementing RBQM.

Despite the broad acknowledgment of RBQM’s benefits, Young noted that practical challenges such as resource constraints and lack of expertise hinder widespread adoption. 

However, he predicts that in five years, RBQM practices will be more integrated into clinical trial management, with standardized protocols and best practices emerging.

Making AI insights actionable

Meanwhile, CluePoints Chief Commercial Officer Patrick Hughes, focusing on branding and the industry landscape, explained the firm’s new brand narrative: “turning artificial intelligence into human intelligence.” 

This approach aims to make AI-driven insights accessible and actionable for clients, leading to improved trial efficiencies and better patient outcomes.

Investments fuel future growth

Hughes also discussed the implications of EQT’s investment in CluePoints, which will enable the company to accelerate growth, enhance technological infrastructure, and expand its global footprint. 

This investment positions CluePoints to bring more innovative solutions to the market and strengthen its leadership in the RBQM and Risk-Based Data Management (RBDM) space.

These experts’ insights highlight the transformative potential of new methodologies and technologies in the pharmaceutical industry, promising improved evaluation and management of outsourcing partners and driving innovation in clinical trials.

Start your
journey today

  • Independent
  • Free
  • Transparent

About OA

Outsource Accelerator is the trusted source of independent information, advisory and expert implementation of Business Process Outsourcing (BPO)

The #1 outsourcing authority

Outsource Accelerator offers the world’s leading aggregator marketplace for outsourcing. It specifically provides the conduit between Philippines outsourcing suppliers and the businesses – clients – across the globe.

The Outsource Accelerator website has over 5,000 articles, 450+ podcast episodes, and a comprehensive directory with 4000+ BPO companies… all designed to make it easier for clients to learn about – and engage with – outsourcing.

About Derek Gallimore

Derek Gallimore has been in business for 20 years, outsourcing for over eight years, and has been living in Manila (the heart of global outsourcing) since 2014. Derek is the founder and CEO of Outsource Accelerator, and is regarded as a leading expert on all things outsourcing.

“Excellent service for outsourcing advice and expertise for my business.”

Learn more
Banner Image
Get 3 Free Quotes Verified Outsourcing Suppliers
3,000 firms.Just 2 minutes to complete.
SAVE UP TO
70% ON STAFF COSTS
Learn more

Connect with over 3,000 outsourcing services providers.

Banner Image

Transform your business with skilled offshore talent.

  • 3,000 firms
  • Simple
  • Transparent
Banner Image